Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events

被引:43
|
作者
Burn, Edward [1 ]
Nghiem, Son [1 ]
Jan, Stephen [2 ]
Redfern, Julie [2 ]
Rodgers, Anthony [2 ]
Thiagalingam, Aravinda [3 ,4 ]
Graves, Nicholas [1 ]
Chow, Clara K. [2 ,3 ,4 ]
机构
[1] Queensland Univ Technol, Brisbane, Qld, Australia
[2] Univ Sydney, George Inst Global Hlth, Sydney Med Sch, Sydney, NSW, Australia
[3] Westmead Hosp, Dept Cardiol, Sydney, NSW, Australia
[4] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; RISK-FACTOR; LIFE-STYLE; SMOKING; HEALTH; MODEL; INTERVENTIONS; INDIVIDUALS; UNCERTAINTY; STROKE;
D O I
10.1136/heartjnl-2016-310195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To estimate the cost-effectiveness of Tobacco, Exercise and Diet Messages (TEXT ME), a text message-based intervention that provides advice, motivation, information and support to improve health-related behaviours. Methods A lifetime Markov model was used to estimate major vascular events (myocardial infarctions and strokes) avoided, quality-adjusted life years (QALYs) gained, costs to the health system and the incremental cost per QALY gained. The model was informed by data from a randomised controlled trial of TEXT ME, with evidence from systematic reviews and meta-analyses used to estimate the effects of changes in risk factors on the risk of major vascular events. Expected costs and health outcomes were estimated with uncertainty surrounding these characterised using probabilistic sensitivity analysis and a number of scenario analyses. Results For a target population of 50 000 patients with documented coronary heart disease, the intervention is expected to lead to 563 fewer myocardial infarctions, 361 fewer strokes and 1143 additional QALYs. TEXT ME is expected to lead to an overall saving of $ 10.56 million for the health system over the patients' lifetimes. The intervention can therefore be considered cost-saving and health-improving. Neither parameter nor structural uncertainty had a significant impact on the conclusion that TEXT ME is cost-effective. Conclusions The provision of TEXT ME is predicted to lead to better health outcomes and an overall saving in costs for the health system.
引用
收藏
页码:923 / U57
页数:8
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PREVENTING CARDIOVASCULAR EVENTS
    Dressel, A.
    ATHEROSCLEROSIS, 2023, 379
  • [12] COST-EFFECTIVENESS OF NOVEL DRUGS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
    Silbernagel, Gunther
    Bilger, Marcel
    ATHEROSCLEROSIS, 2024, 395
  • [13] Primary prevention of cardiovascular disease: a cost-effectiveness comparison
    Franco, O
    De Laet, C
    Der Kinderen, A
    Peeters, A
    Bonneux, L
    EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [14] Primary prevention of cardiovascular disease: Cost-effectiveness comparison
    Franco, Oscar H.
    Kinderen, Arno J. der
    De Laet, Chris
    Peeters, Anna
    Bonneux, Luc
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 71 - 79
  • [15] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    CIRCULATION, 2004, 110 (17) : 802 - 802
  • [16] Cost-effectiveness of primary and secondary prevention in cardiovascular diseases
    Troche, CJ
    Tacke, J
    Hinzpeter, B
    Danner, M
    Lauterbach, KW
    EUROPEAN HEART JOURNAL, 1998, 19 : C59 - C65
  • [17] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
  • [18] COST-EFFECTIVENESS OF ATORVASTATIN VERSUS SIMVASTATIN IN PREVENTION OF CARDIOVASCULAR EVENTS FROM A THAILAND SOCIETAL PERSPECTIVE
    Sukonthasarn, A.
    Thongtang, N.
    Ektare, V
    Du, F.
    Brizuela, G.
    Rustagi, S.
    Gao, X.
    VALUE IN HEALTH, 2021, 24 : S70 - S70
  • [19] Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
    Liang, Zhe
    Chen, Qi
    Wei, Ruiqi
    Ma, Chenyao
    Zhang, Xuehui
    Chen, Xue
    Fang, Fang
    Zhao, Quanming
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [20] Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
    Petersohn, Svenja
    Pouwels, Xavier
    Ramaekers, Bram
    ten Cate-Hoek, Arina
    Joore, Manuela
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (13) : 1354 - 1365